Government Affairs
Refine Search
Pharmaceutical
According to contingency plans drawn up by the USA’s Department of Health and Human Services, 45% of the Food and Drug Administration’s nearly 15,000 staff were to be furloughed in the absence of enacted annual appropriations – popularly referred to as a government shutdown, say Ricardo Carvajal and Kurt Karst on law firm Hyman, Phelps & McNamara’s FDA Law Blog, commenting on the stalemate resulting from the failure of agreement on the US budget. 2 October 2013
Pharmaceutical
Japan’s Central Social Insurance Medical Council held a meeting last week of its Drug Pricing Subcommittee where pharma representatives presented their opinions on the revision of drug pricing rules slated for April 2014. 30 September 2013
Pharmaceutical
US Senator Charles Grassley has written to two drug companies on behalf of an Iowa hospital that is not receiving required discounts on two drugs, despite a federal program to help uninsured patients. 27 September 2013
Generics
Humanitarian group Médecins Sans Frontières has warned that India is facing political pressure from the US government and pharmaceutical industry in retaliation for the country’s patenting practices. 25 September 2013
Generics
Australia’s Generic Medicines Industry Association strongly refutes claims by the Consumer Health Forum that Australian taxpayers and consumers are over paying for generic medicines by A$2,000 a minute. 24 September 2013
Pharmaceutical
The UK Parliament's Science and Technology Committee has described the current lack of transparency of many clinical trials as "unacceptable," adding that it has not been impressed with government efforts to tackle the problem to date. 17 September 2013
Pharmaceutical
As has been largely expected, Australia's Prime Minister-elect Tony Abbott has this morning appointed former Shadow Minister for Health & Aging Peter Dutton to lead the Health portfolio (The Pharma Letter September 9) but surprised by dropping the role of parliamentary secretary, nine days after the coalition's election win over Labor. Deputy Leader in the Senate Fiona Nash has been named Assistant Health Minister. 16 September 2013
Pharmaceutical
The result of Australia's election on Saturday could have wider implications for the country's pharmaceutical industry. 9 September 2013
Pharmaceutical
The Russian government is considering ways of saving on the purchase of drugs, which is expected to take place through the re-registration of all the drugs (and in particular those which are subject of state purchases), limitation of public procurement for essential/vital drugs, as well as the introduction of reference prices. 3 September 2013
Biotechnology
Work to gather sector views for the development of a Life Science Manifesto for the 2015-20 Parliament is well underway as part of the collaboration bringing together the UK's BioIndustry Association (BIA), Bionow, BioPartner UK and One Nucleus. 2 September 2013
Pharmaceutical
Ahead of Australia's federal election on September 7, the Greens' leader, Senator Christine Milne, launched the party's A$9 billion ($8.0 billion) national health package in Canberra this week, which includes a commitment to the country's Pharmaceutical Benefits Scheme (PBS). 29 August 2013
Biotechnology
In the USA this week, the California Assembly has passes legislation that would allow pharmacists to dispense biosimilars, substitute medicines that are biologically similar to brand-name treatments, after notifying prescribing doctors, according to various media reports. SB598 passed the Assembly on Monday on a 58-four vote and returns to the Senate for a final vote. 29 August 2013
Pharmaceutical
Ahead of the federal election scheduled for September 7, trade group AusBiotech has welcomed the Australian Coalition's policy aimed to boost the competitiveness of Australian manufacturing. 27 August 2013
Pharmaceutical
The Japanese Prime Minister, Shinzo Abe, last week held a meeting of the Council for Regulatory Reform (CRR). The council proposed to the Prime Minister revision of drug pricing rules so as to give higher reimbursement prices for innovative new drugs and encourage pharmaceutical companies to conduct more R&D in Japan. 27 August 2013
Pharmaceutical
The Russian government is considering providing permission for the state purchases of essential drugs, in accordance with their brand names, but in line with protection of their chemical formula by patents and the existence of evidences that the drug cannot be replaced by its analogue. 26 August 2013
Biotechnology
Trade group AusBiotech has commended the Australian Labor government's response to the Strategic Review of Health and Medical Research (The McKeon Review; The Pharma Letter April 5) and its pledge to establish the A$250 million($230 million) Medical Research Innovation Fund (MRIF). 22 August 2013
Pharmaceutical
Ahead of the September 7 elections, Australian Coalition Senators have issued a statement acknowledging the many strengths of Australia's existing Pharmaceutical Benefits Scheme (PBS). Overall the PBS delivers to the Australian community a wide range of both older and newer prescription medicines in a way that offers patients a high degree of confidence that they are of high quality, safe and compared to the cost of medicines in some other countries, reasonably priced, they said. 22 August 2013
Pharmaceutical
The BioIndustry Association (BIA), the UK trade association for the innovative biotechnology sector, warned yesterday (August 15) that the government's proposed pricing regime for branded medicines in the UK will put at risk future investment in the UK biotech base. 20 August 2013
Pharmaceutical
As largely expected, Brazilian President Dilma Rousseff has signed the Brazilian Clean Companies Act, according to a comprehensive report from law firm Covington & Burling, which, though not specifically targeted as the sector, will clearly have implications for pharmaceutical companies, both domestic firms and multinationals doing business in that country. 15 August 2013
Pharmaceutical
Members of the Association of Innovative Pharmaceutical Industry (AIFP) and the Czech Association of Pharmaceutical Companies (CAFF) have pointed out the unlawfulness of the abolition of the suspensory effect of appeals against administrative decisions, as proposed by the Ministry of Health within the planned short-term savings of drug expenditures, according to a web posting by the AIFP. 11 August 2013
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze